Monday, September 8, 2025

Curaleaf Receives 5 Adult-Use License Approvals in Home State

Curaleaf Holdings (CSE: CURA) announced this afternoon that it has received approval for five adult use licenses in its home state of Massachusetts. Three of the licenses are final licenses, while two are considered provisional.

Of the five licenses granted in total, three are for the co-location of adult-use activities at currently licensed medical properties. One final license is for adult use sales at a currently medical-only dispensary in Oxford, Mass, while the two other final licenses are for adult-use cultivation and manufacturing at a currently operational facility in Webster, Mass.

The two provisional licenses are for retail locations in Provincetown, and Ware. Hanover appears to be the only medical dispensary which will not presently be licensed for adult-use products.

The final adult-use licenses will still require “Post final” inspections, as well as “Commence Operations” inspections, which are expected to occur in the coming months as per the company news release.

Curaleaf Holdings is currently trading at $10.17, up 3.67% on todays news that Cowen & Company had assigned the firm a price target of US$10.50 and a rating of outperform while initiating coverage on the company.


Information for this briefing was found via Curaleaf Holdings. The author has no securities or affiliations related to the discussed organizations. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Avino Q2 Earnings: Steady As She Goes

MEG Energy: Cenovus Comes In With $7.9 BILLION Offer

Orla Mining Q2 Earnings: Musselwhite Changes Everything

Recommended

Goliath Resources Hits 18.58 g/t Gold Over 5.00 Metres At Surebet

ESGold Outlines $24.3 Million NPV For Tailings Reprocessing Project

Related News

Curaleaf Sees Grassroots Shareholders Approve Transaction

Curaleaf Holdings (CSE: CURA) announced this morning that the shareholders of GR Companies, known as...

Friday, July 17, 2020, 01:20:06 PM

Curaleaf Sees Numerous Analysts Raise Price Targets Following Third Quarter Results

On Tuesday, Curaleaf Holdings (CSE: CURA) reported their third quarter results. The company reported total...

Saturday, November 21, 2020, 01:27:00 PM

Curaleaf Acquires Final Portion of Florida Operations For C$31.9 Million

Curaleaf Holdings (CSE: CURA) has finally acquired the final portion of its Florida assets as...

Sunday, August 23, 2020, 01:35:00 PM

Curaleaf Closes US$211 Cash Purchase Of Bloom Dispensaries

Curaleaf Holdings (CSE: CURA) has completed its previously announced US$211 million acquisition of Bloom Dispensaries....

Wednesday, January 19, 2022, 08:57:26 AM

Curaleaf Closes European Transaction, Immediately Sells 31.5% Stake To Undisclosed Strategic Investor

Curaleaf Holdings (CSE: CURA) this morning announced the completion of EMMAC Life Sciences, a vertically...

Wednesday, April 7, 2021, 08:38:43 AM